Related Experiment Videos
Kappa-chain nephropathy associated with plasma cell leukemia.
Archives of Internal Medicine
|August 1, 1984
Summary
Plasma cell leukemia (PCL) can cause kidney damage, specifically kappa-chain nephropathy. This case highlights PCL as another plasma cell disorder linked to kidney disease from protein light chains.
Area of Science:
- Nephrology
- Hematology
- Oncology
Background:
- Plasma cell dyscrasias are a group of disorders characterized by the proliferation of abnormal plasma cells.
- These disorders can lead to the production of abnormal proteins, such as immunoglobulin light chains, which can deposit in organs like the kidneys.
- Renal insufficiency is a known complication of several plasma cell dyscrasias.
Observation:
- A 45-year-old woman presented with plasma cell leukemia (PCL), a rare and aggressive form of multiple myeloma.
- The patient also exhibited mild renal insufficiency.
- Renal biopsy was performed to investigate the cause of kidney dysfunction.
Findings:
- Renal biopsy findings were consistent with kappa-chain nephropathy, indicating deposition of kappa immunoglobulin light chains in the renal tissue.
- This specific finding links the patient's PCL to a particular type of kidney damage.
Implications:
- This case expands the spectrum of plasma cell dyscrasias associated with kappa- and/or lambda-chain nephropathy.
- It underscores the importance of considering PCL in the differential diagnosis of light chain nephropathy, even with seemingly mild renal impairment.
- Further research may elucidate the precise mechanisms linking PCL and specific light chain nephropathies.